Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Ovarian Neoplasms 3 Breast Neoplasms 3 Polycythemia Vera 2 Myeloproliferative Disorders 2 Lymphoma 2 Lung Neoplasms 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Thymic aplasia 1 Squamous Cell Carcinoma of Head and Neck 1 Small Cell Lung Carcinoma 1 Severe Combined Immunodeficiency 1 Salivary Gland Neoplasms 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Primary Dysautonomias 1 Polycystic Ovary Syndrome 1 Neuroblastoma 1 Neoplasms 1 Mucopolysaccharidosis I 1 Metabolic Syndrome 1 Melanoma 1 Liver Neoplasms 1 Kidney Neoplasms 1 Insulin Resistance 1 Immunologic Deficiency Syndromes 1 Hyperandrogenism 1 Hodgkin Disease 1 Hematologic Neoplasms 1

Interventions

Sorafenib 42 Bevacizumab 16 Oxaliplatin 13 Radiosurgery 10 Gemcitabine 10 Doxorubicin 10 Capecitabine 10 Leucovorin 9 Hepatectomy 9 Fluorouracil 9 Cisplatin 9 Radiofrequency Ablation 8 Nivolumab 8 pembrolizumab 7 Drug Therapy 7 Carboplatin 7 Irinotecan 6 Cryosurgery 6 Talaporfin 5 Mitomycin 5 Everolimus 5 Erlotinib Hydrochloride 5 Electroporation 5 spartalizumab 4 Sunitinib 4 Melphalan 4 Ipilimumab 4 Epirubicin 4 Embolization, Therapeutic 4 regorafenib 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Liver Neoplasms × Phlebotomy × Clear all

NCT02548910 2021-03-18

PRICE

Ottawa Hospital Research Institute

Phase NA Completed

62 enrolled 13 charts

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡